Related Experiment Video
Updated: May 20, 2026

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection
Nikolaos Papadantonakis1, Shinobu Matsuura, Katya Ravid
1Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA. kravid@bu.edu
Abstract:
Megakaryocytes (MKs), the platelet precursors, are capable of accumulating DNA greater than a diploid content as part of their cell cycle. MKs have been recognized as mediating fibrosis in a subset of hematologic malignancies, including acute megakaryoblastic leukemia and a subset of myeloproliferative neoplasms. The mechanisms responsible for fibrosis remain only partially understood. Past studies highlighted the role of growth factors in such pathologies, and recently, the protein lysyl oxidase (LOX) has been implicated in proliferation of MKs, ploidy and deposition of fibers. LOX was initially characterized as a protein responsible for the intermolecular cross-linking of elastin and collagen, and in recent years it has been identified as regulator of various pathologies, such as cancer and inflammation. Here, we review recent advances in the understanding of the contribution of MKs to the progression of myelofibrosis, highlighting the newly identified role of LOX.
Insights
Megakaryocytes (MKs) contribute to myelofibrosis, a condition causing fibrosis in blood cancers. The protein lysyl oxidase (LOX) plays a newly identified role in MK proliferation and fibrosis progression.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Megakaryocytes (MKs), the precursors to platelets, undergo DNA replication during their cell cycle.
- MKs are implicated in mediating fibrosis in certain hematologic malignancies, such as acute megakaryoblastic leukemia and myeloproliferative neoplasms.
- The precise mechanisms driving fibrosis in these conditions are not fully elucidated.
Purpose of the Study:
- To review recent advancements in understanding the role of MKs in myelofibrosis progression.
- To highlight the newly identified contribution of lysyl oxidase (LOX) in this process.
Main Methods:
- Literature review of studies on MKs, fibrosis, and lysyl oxidase (LOX).
Main Results:
- Lysyl oxidase (LOX) has been recently implicated in MK proliferation, DNA content changes (ploidy), and extracellular matrix deposition.
- LOX is known for its role in cross-linking collagen and elastin, contributing to tissue structure.
- LOX is increasingly recognized as a regulator in various pathological conditions, including cancer and inflammation.
Conclusions:
- Megakaryocytes (MKs) are key players in the development of myelofibrosis.
- Lysyl oxidase (LOX) emerges as a significant factor in MK-driven fibrosis, warranting further investigation.
Related Concept Videos
Lysosomal Hydrolases
Osteoclasts in Bone Remodeling